Canada markets open in 9 hours 11 minutes

Syndax Pharmaceuticals, Inc. (SNDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.13-0.15 (-0.70%)
At close: 04:00PM EDT
21.13 0.00 (0.00%)
After hours: 05:35PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.80B
Enterprise Value 1.22B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.24
Enterprise Value/Revenue 7.85
Enterprise Value/EBITDA -5.83

Trading Information

Stock Price History

Beta (5Y Monthly) 0.98
52-Week Change 33.68%
S&P500 52-Week Change 323.10%
52 Week High 325.34
52 Week Low 311.22
50-Day Moving Average 322.59
200-Day Moving Average 319.08

Share Statistics

Avg Vol (3 month) 31.08M
Avg Vol (10 day) 3907.8k
Shares Outstanding 584.98M
Implied Shares Outstanding 685.89M
Float 884.63M
% Held by Insiders 10.82%
% Held by Institutions 1106.42%
Shares Short (Apr 15, 2024) 49.6M
Short Ratio (Apr 15, 2024) 48.36
Short % of Float (Apr 15, 2024) 411.39%
Short % of Shares Outstanding (Apr 15, 2024) 411.30%
Shares Short (prior month Mar 15, 2024) 48.33M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-25.89%
Return on Equity (ttm)-40.99%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -229.94M
Net Income Avi to Common (ttm)-209.36M
Diluted EPS (ttm)-2.98
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)577.58M
Total Cash Per Share (mrq)6.8
Total Debt (mrq)1.64M
Total Debt/Equity (mrq)0.29%
Current Ratio (mrq)10.00
Book Value Per Share (mrq)6.53

Cash Flow Statement

Operating Cash Flow (ttm)-160.6M
Levered Free Cash Flow (ttm)-82.37M